ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
68,051.59
0.69%
S&P 500
5,266.95
-0.74%
Dow Jones
38,441.54
-1.06%
US Dollar vs Yen
157.366
-0.16%
Brent Oil
83.355
-0.02%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Supernus Pharmaceuticals Inc (SUPN)

  7. Supernus Pharmaceuticals Inc (SUPN) ニュース

SUPN

Supernus Pharmaceuticals (SUPN)

Supernus Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:SUPN
日付受信時刻ニュースソース見出しコード企業名
2024/05/2405 : 25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/05/2405 : 05GlobeNewswire Inc.Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in EpilepsyNASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/05/1005 : 09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/05/1005 : 05GlobeNewswire Inc.Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa Study of SPN-817 for Treatment-Resistant SeizuresNASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/05/0905 : 11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/05/0905 : 11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/05/0905 : 08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/05/0905 : 05GlobeNewswire Inc.Supernus Announces First Quarter 2024 Financial ResultsNASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/05/0723 : 00PR Newswire (US)M8 Pharmaceuticals, an Acino company, signs an exclusive licensing agreement with Supernus for Qelbree® (Viloxazine XR) in Latin AmericaNASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/05/0121 : 00GlobeNewswire Inc.Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree StoryNASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/04/2505 : 05GlobeNewswire Inc.Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024NASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/04/0821 : 00GlobeNewswire Inc.Supernus Provides Regulatory Update for SPN-830NASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/03/0706 : 30GlobeNewswire Inc.Supernus to Participate in Two Upcoming Investor ConferencesNASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/03/0107 : 01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/03/0107 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/02/2907 : 01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/02/2907 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/02/2906 : 30GlobeNewswire Inc.Supernus to Participate in the TD Cowen 44th Annual Healthcare ConferenceNASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/02/2807 : 04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/02/2807 : 03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/02/2807 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/02/2807 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/02/2807 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/02/2806 : 14Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/02/2806 : 05GlobeNewswire Inc.Supernus Announces Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/02/2707 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/02/2707 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/02/2707 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/02/2707 : 01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
2024/02/2707 : 01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SUPNSupernus Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SUPN

最近閲覧した銘柄

LSE
17YM
Investec Bnk 28
EU
OP8E
Ossiam IRL ICAV
COIN
XVPBTC
BIT
P1T2H1
BNP Paribas Issuance
COIN
PIGGYEUR
BIT
P1P2X2
BNP Paribas Issuance
BIT
P14GK0
BNP Paribas Issuance
BIT
P1STI6
BNP Paribas Issuance
EU
CLPDS
Colipays DS
BIT
P1AK99
BNP Paribas Issuance
BIT
F34695
Vontobel Financial Produ...
TG
1ZB
Bloom Energy
EU
0335T
0335T
EU
5281T
5281T
BIT
P1M2P1
BNP Paribas Issuance
BIT
P1IAJ5
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有